Beyond Medical Technologies Inc. (C:DOCT*CA)
| Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
| See Regulatory Filings on SEDAR | |
| Company Contact | |
| Address: | Suite 915, 700 West Pender Street VANCOUVER BC V6C 1G8 |
| Tel: | N/A |
| Website: | https://www.beyondmd.ca |
| IR: | See website |
| Key People | ||
| Alfred Wong President, Chief Executive Officer | Michael S. M. Sadhra Chief Financial Officer | Bharat Bhushan Chief Technology Officer, Director |
| Business Overview |
| Beyond Medical Technologies Inc. is a Canada-based industrial/technology company. The Company is engaged in the research and development of its waste digester business in the food and pharmaceuticals industries. The Company also manufactures personal protective equipment (PPE), including medical grade face masks through its subsidiary, Micron Technologies Inc. (MTI). Its businesses include Medical Mask Manufacturing and Digital Telehealth Platform. The Company develops its Organivore and Pharmavore waste digesters using its own technology. The Company, through MTI, is also manufacturing and distributing medical grade face masks compliant with ASTM F2100 Standards. The Company through its subsidiary, Kayan Health Limited, provides Kayan Health. Kayan Health artificial intelligence powered health communications platform that helps doctors streamline communications with their patients and remotely monitor them. The Company operates through two segments: Waste Treatment and PPE Sector. |
| Financial Overview |
| For the fiscal year ended 31 December 2021, Beyond Medical Technologies Inc revenues increased from C$209K to C$943K. Net loss decreased 55% to C$2.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Loss on acquisition of Covid Technologie decrease from C$4.2M (expense) to C$0K, Consulting fees decrease of 85% to C$90K (expense). |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $0.62M as of Dec 31, 2021 |
| Annual revenue (TTM): | $0.94M as of Dec 31, 2021 |
| EBITDA (TTM): | -$1.94M as of Dec 31, 2021 |
| Net annual income (TTM): | -$2.91M as of Dec 31, 2021 |
| Free cash flow (TTM): | -$1.40M as of Dec 31, 2021 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 79,139,750 as of Dec 31, 2021 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2022 INK Research Corp. All rights reserved.
US Quotes Data provided by IEX. Company fundamental and price data sourced from © Refinitiv. Click for restrictions. © Refinitiv. All rights reserved. Republication or redistribution of Refinitiv, including by framing or similar means, is prohibited without the prior written consent of Refinitiv. Refinitiv is not liable for any errors or delays in Refinitiv content, or for any actions taken in reliance on such content.
US Quotes Data provided by IEX. Company fundamental and price data sourced from © Refinitiv. Click for restrictions. © Refinitiv. All rights reserved. Republication or redistribution of Refinitiv, including by framing or similar means, is prohibited without the prior written consent of Refinitiv. Refinitiv is not liable for any errors or delays in Refinitiv content, or for any actions taken in reliance on such content.